BA
NWBO

Bristlecone Advisors’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

Bristlecone Advisors’s Portfolio NWBO Stock Details NWBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,075
Closed – – 284
2017
Q3 		$0 Buy
+1,075
New – ﹤0.01% 293